Home > Products > Biosimilars

BioSIM anti-Human complement C5 Antibody (Eculizumab Biosimilar), Research Grade

Catalog: SIM0327
Cost advantage to: SIM0011
Isotype: IgG2-G4-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic Eculizumab biosimilar, sharing the same variable regions as the therapeutic version, is ideal for research. It binds human terminal complement component C5 (a liver-synthesized precursor). During complement activation, C5 cleaves into C5α/C5β; C5α further splits, forming C5b that recruits C6-C9 to make MAC (destroying pathogens via lytic pores). Eculizumab inhibits C5 cleavage and treats PNH and aHUS.
 

Specifications

Product Name BioSIM anti-Human complement C5 Antibody (Eculizumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG2-G4-kappa
Target complement C5
Other Names 5G1.1, h5G1.1HuG2/G4, CAS: 219685-50-4
CAS 219685-50-4
Reactivity Human
Host Species Humanized
Background This non-therapeutic Eculizumab biosimilar, sharing the same variable regions as the therapeutic version, is ideal for research. It binds human terminal complement component C5 (a liver-synthesized precursor). During complement activation, C5 cleaves into C5α/C5β; C5α further splits, forming C5b that recruits C6-C9 to make MAC (destroying pathogens via lytic pores). Eculizumab inhibits C5 cleavage and treats PNH and aHUS.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products